Fentanyl and the Current State of the Opioid Epidemic
Last year, our country hit a grim milestone. Overdose deaths surpassed 100,000 for the first time in a 12-month period. More than 64,000 of these
5 Reasons Telemedicine is the Future of Health Care
Telemedicine involves the use of electronic communications and software like computers, video, phones, or messaging to provide clinical services to patients virtually. Telemedicine can effectively
Opioid Poisoning in Young Children: What You Should Know
Poisoning can happen to people of all ages, but incidences disproportionately affect children younger than six years old, with peak poison frequency occurring in one and two-year-olds.
Opioid Use Among Teens: Let’s Talk About It
Opioids are medications prescribed by doctors to treat pain. They are called opioids because they attach to the opioid receptors in the brain and throughout
6 Reasons the Pandemic Worsened the Opioid Epidemic
The United States has been fighting an opioid epidemic since the late 1990s. Unfortunately, much of our progress has backtracked during the COVID-19 pandemic. Not
6 Ways Opioids Can Hurt Your Heart
Opioids are a drug class used to reduce pain. They work by binding to opioid receptors throughout the body to block pain messages sent to the brain
Forward-looking and cautionary statements:
Statements made on our website may contain “forward-looking information” as defined in applicable Canadian securities legislation. All statements other than statements of historical fact included in this release, including, without limitation, future operating margins, future production and processing, processing results, and future plans and objectives of Vivera, constitute forward looking information that involve various risks and uncertainties. Forward-looking information is based on a number of factors and assumptions which have been used to develop such information but which may prove to be incorrect, including, but not limited to, assumptions in connection with the continuance of Vivera and its subsidiaries as a going concern, general economic and market conditions, price of biomass, the accuracy of production resource estimates, and the performance of Vivera’s future operations. There can be no assurance that such information will prove to be accurate and actual results and future events could differ materially from those anticipated in such forward-looking information. Important factors that could cause actual results to differ materially from Vivera’s expectations include but are not limited to: changes in economic conditions or financial markets; increases in costs; litigation; legislative, environmental and other judicial, regulatory, political and competitive developments; and technological or operational difficulties. This list is not exhaustive of the factors that may affect our forward-looking information. These and other factors should be considered carefully, and readers should not place undue reliance on such forward-looking information. For additional information with respect to risk factors applicable to Vivera, reference should be made to Vivera’s continuous disclosure materials filed from time to time with securities regulators, including, but not limited to, Vivera’s CSE Listing Statement. The forward-looking information contained on our website is made as of the date of the release of such statement and Vivera does not intend, and expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law. The CSE has not reviewed, approved or disapproved the contents on our site.
